Glomerulonephritis membranoproliferative – Basic Information

Go back

Membranoproliferative glomerulonephritis is a rare kidney disorder that causes inflammation and structural changes in the tiny filtering units of the kidneys. Understanding this complex condition can help patients and their families navigate the challenges of diagnosis, treatment, and long-term management.

What Is Membranoproliferative Glomerulonephritis?

Membranoproliferative glomerulonephritis, often shortened to MPGN, is a kidney disorder that involves inflammation and changes to the cells within the kidneys. The condition affects structures called glomeruli, which are tiny filtering units in the kidneys that help remove waste products and excess fluids from the blood to form urine. When these filters become damaged, the kidneys cannot work properly, and this can lead to serious health problems over time.[1]

The disease gets its name from the way it looks under a microscope. “Membrano” refers to the thickening of the membrane that surrounds the glomeruli, while “proliferative” describes the increase in the number of cells in these structures. These changes make it harder for the kidneys to filter blood effectively, which can allow important substances like protein and blood cells to leak into the urine when they should stay in the bloodstream.[1]

This condition is uncommon, meaning it does not affect large numbers of people compared to more common kidney diseases. However, when it does occur, it can have significant effects on a person’s health and quality of life. The disease can progress slowly over time, and without proper management, it may eventually lead to kidney failure, where the kidneys can no longer function well enough to sustain life without treatment such as dialysis or kidney transplant.[6]

Epidemiology: Who Gets This Disease?

Membranoproliferative glomerulonephritis primarily affects children and young adults, though it can occur at any age. The disease is most commonly diagnosed in people between the ages of 8 and 30 years. In children specifically, it appears most frequently between ages 2 and 15, and it accounts for less than 10 percent of cases of nephrotic syndrome (a condition where the kidneys leak large amounts of protein into the urine) in this age group.[4][5]

The condition affects men and women equally, meaning there is no difference in risk based on gender. When the disease occurs in adults, particularly those over 30 years of age, it is more likely to be related to another underlying health condition rather than occurring on its own.[5]

The primary form of MPGN, where no underlying cause can be found, is becoming less common than it was in the past. Today, secondary forms of the disease—those linked to other health conditions—are more frequently diagnosed. This shift has occurred partly because doctors have become better at identifying underlying causes, such as chronic infections with viruses like hepatitis C, which were previously thought to be cases of primary MPGN.[6]

MPGN is considered a rare disease overall, accounting for approximately 7 percent of causes of nephrotic syndrome in adults.[15] Some cases appear to run in families, suggesting that genetic factors may play a role in at least some instances of the disease.[4]

Causes of Membranoproliferative Glomerulonephritis

The causes of membranoproliferative glomerulonephritis can be divided into two main categories: primary (also called idiopathic) and secondary. Understanding which type a person has is important because it affects treatment decisions and outcomes.

Primary MPGN occurs when the disease develops without any identifiable underlying cause. In these cases, researchers believe the body’s immune system mistakenly attacks the kidneys. This happens when abnormal immune responses cause deposits of antibodies to build up in a part of the kidney called the glomerular basement membrane. This membrane is crucial for filtering blood properly, and when it becomes damaged by these deposits, the kidney’s ability to create urine normally is affected.[1]

Secondary MPGN is more common and occurs when the kidney damage is caused by another disease or condition. A majority of MPGN cases are now recognized as secondary forms. Many different conditions can trigger secondary MPGN, and identifying the underlying cause is essential for proper treatment.[4]

Chronic infections are one of the most common causes of secondary MPGN. Viral infections such as hepatitis B and hepatitis C are particularly important triggers. In fact, mixed cryoglobulinemia associated with chronic hepatitis C infection has been found to cause many cases that were previously thought to be idiopathic. Other infections that can lead to MPGN include bacterial endocarditis (an infection of the heart valves), HIV infection, visceral abscesses, infections related to ventriculoatrial shunts, and parasitic infections such as malaria.[4][6]

Autoimmune diseases, where the body’s immune system attacks its own tissues, can also cause MPGN. These include systemic lupus erythematosus (commonly called lupus), scleroderma, Sjögren syndrome, and rheumatoid arthritis. In these conditions, the immune system creates complexes that deposit in the kidneys and cause damage.[1][4]

Certain cancers can trigger MPGN as well. These include blood cancers such as leukemia and lymphoma, as well as conditions involving abnormal production of proteins by the immune system, such as monoclonal gammopathy and multiple myeloma.[4][6]

⚠️ Important
The classification of MPGN has evolved significantly in recent years. Doctors now classify the disease based on what causes it and what they see when examining kidney tissue under special microscopes, rather than just by appearance alone. This newer classification helps doctors choose the most appropriate treatment for each patient’s specific type of MPGN.

Risk Factors

Certain factors increase the likelihood of developing membranoproliferative glomerulonephritis. Age is one important factor, as the disease most commonly affects children between 2 and 15 years of age and young adults between 8 and 30 years. People in these age groups should be aware of kidney-related symptoms and seek medical attention if they notice changes in their urine or unexplained swelling.[4][5]

Having certain chronic infections significantly raises the risk of developing secondary MPGN. People with chronic hepatitis B or C infections are at higher risk, which is why regular medical monitoring is important for these individuals. Similarly, those with HIV infection or chronic bacterial infections such as endocarditis need to be aware of this potential complication.[4]

Individuals with autoimmune diseases, particularly systemic lupus erythematosus, are at increased risk for developing MPGN. If you have been diagnosed with an autoimmune condition, regular kidney function monitoring is important to catch any problems early. The same applies to people with other immune system disorders like Sjögren syndrome or rheumatoid arthritis.[4]

People with certain types of cancer, especially blood cancers like leukemia, lymphoma, or conditions involving abnormal protein production such as multiple myeloma, face a higher risk of developing MPGN. Regular health screenings can help identify kidney problems early in these populations.[4]

Family history may also play a role, as some cases of MPGN appear to run in families. This suggests that genetic factors might increase susceptibility to the disease in certain individuals, although this is not fully understood.[4]

Symptoms and How They Affect Daily Life

The symptoms of membranoproliferative glomerulonephritis can vary greatly from person to person. Some individuals may have few or no noticeable symptoms, while others experience significant problems that affect their daily activities. The symptoms often develop gradually rather than suddenly, which can make them easy to overlook at first.[5]

One of the most common signs is changes in the urine. Many people notice blood in their urine, which may make it appear dark, smoky, cola-colored, or tea-colored. The urine might also look cloudy or frothy, especially if large amounts of protein are being leaked from the kidneys. Some people notice a decrease in the amount of urine they produce. These changes happen because the damaged glomeruli allow blood cells and proteins to pass through into the urine when they should remain in the bloodstream.[1][5]

Swelling, medically called edema, is another common symptom. This swelling typically occurs in the legs and ankles but can affect any part of the body, including the face and hands. It happens because when the kidneys leak too much protein into the urine, the protein levels in the blood drop. This causes fluid to leak out of blood vessels into body tissues. The swelling can make it uncomfortable to wear shoes, make your legs feel heavy, or cause your face to appear puffy, especially in the morning.[1][5]

High blood pressure is frequently present in people with MPGN. You may not feel high blood pressure directly, but it can cause headaches, dizziness, or make you feel unwell. Over time, uncontrolled high blood pressure can cause further damage to the kidneys and other organs.[1]

When kidney function declines significantly, waste products can build up in the blood, a condition called azotemia. This can cause various symptoms including fatigue, lack of energy, decreased appetite, nausea, and changes in mental status such as decreased alertness or difficulty concentrating. These symptoms occur because the kidneys are no longer effectively removing toxic waste products from the bloodstream.[1]

Some patients develop what doctors call nephrotic syndrome, which is a collection of symptoms including heavy protein loss in the urine (usually more than 3 grams in 24 hours), low protein levels in the blood, significant swelling, and often high cholesterol levels. In severe cases, nephrotic syndrome can increase the risk of developing blood clots and infections.[5]

It is important to note that some people with MPGN have asymptomatic disease, meaning they have no obvious symptoms. In these cases, the condition might only be discovered during routine medical tests or when checking urine for another reason. This is why regular health check-ups are important, especially for people with risk factors for kidney disease.[5]

Prevention

While primary membranoproliferative glomerulonephritis cannot always be prevented because its exact cause is unknown, there are steps that can reduce the risk of developing secondary MPGN or slow its progression once diagnosed.

Preventing and treating infections promptly is one of the most important preventive measures. Since chronic viral infections, particularly hepatitis B and hepatitis C, are major causes of secondary MPGN, protecting yourself against these infections is crucial. Vaccination against hepatitis B is available and recommended for people at risk. If you have been diagnosed with hepatitis C, proper treatment of the infection can help prevent MPGN from developing or progressing.[1]

Managing autoimmune diseases effectively is another key preventive strategy. If you have lupus or another autoimmune condition, working closely with your doctor to control the disease through appropriate medications and lifestyle measures can help protect your kidneys. Regular monitoring of kidney function through blood and urine tests allows early detection of any problems.[1]

Maintaining a healthy lifestyle supports overall kidney health. This includes eating a balanced diet, staying physically active, maintaining a healthy weight, not smoking, and limiting alcohol consumption. These general health measures help reduce stress on the kidneys and support the immune system.

For people already diagnosed with MPGN, dietary modifications may be recommended by healthcare providers. Changes might include limiting sodium (salt) to help control blood pressure and reduce swelling, moderating protein intake to reduce the workload on the kidneys, and controlling fluid intake if swelling is a problem. These dietary changes should be made under medical supervision, as individual needs vary greatly.[1]

Regular medical check-ups and monitoring are essential for people at risk. This is especially important for those with chronic infections, autoimmune diseases, or a family history of kidney problems. Blood tests to check kidney function and urine tests to detect protein or blood can identify problems early when treatment may be most effective.[1]

Controlling blood pressure is vital for protecting the kidneys. If you develop high blood pressure, working with your doctor to keep it well-controlled through medication and lifestyle changes can help slow the progression of kidney disease.

Pathophysiology: How the Disease Affects the Body

Understanding how membranoproliferative glomerulonephritis affects the kidneys helps explain why symptoms occur and why treatment is important. The disease causes specific changes in the structure and function of the glomeruli, the tiny filtering units within the kidneys.

In a healthy kidney, the glomeruli act like tiny sieves, allowing waste products and excess fluids to pass through while keeping important substances like proteins and blood cells in the bloodstream. Each glomerulus is made up of a network of tiny blood vessels surrounded by a membrane called the glomerular basement membrane. This membrane is crucial for proper filtering.

In MPGN, the disease process damages this delicate filtering system in several ways. First, there is proliferation, meaning an abnormal increase in the number of cells within the glomeruli. Both mesangial cells (which support the structure of the glomeruli) and endothelial cells (which line the blood vessels) multiply excessively. Additionally, the mesangial matrix, a supporting tissue within the glomeruli, expands.[2]

Second, the peripheral capillary walls (the outer walls of the tiny blood vessels in the glomeruli) become thickened. This thickening occurs because of deposits that accumulate in specific locations. In some types of MPGN, these deposits consist of immune complexes made of antibodies and other proteins. In other types, the deposits are mainly complement proteins, which are part of the immune system’s defense mechanism.[2]

These deposits and cellular changes create a characteristic appearance under the microscope. The capillary walls may show a “double-contour” or “tram-track” appearance, which happens when mesangial cells and matrix push into the capillary wall, creating what looks like a second layer of basement membrane. This distinctive pattern is one of the hallmarks that helps doctors diagnose MPGN.[2]

An important feature of MPGN is abnormal complement activation. The complement system is part of the body’s immune defense, consisting of proteins that normally help fight infections. In MPGN, this system becomes dysregulated. Depending on the type of MPGN, either the classical complement pathway or the alternative complement pathway becomes overactive. This excessive complement activation contributes to the damage of the glomeruli and is why many patients with MPGN have low levels of complement proteins in their blood, a condition called hypocomplementemia.[2][6]

As these structural changes accumulate, the glomeruli become less effective at filtering blood. The damaged basement membrane becomes leaky, allowing protein to pass through into the urine. This protein loss, called proteinuria, can be substantial. When enough protein leaks out, the protein concentration in the blood drops. Because proteins help keep fluid inside blood vessels, their loss causes fluid to leak into surrounding tissues, resulting in swelling.[1]

Blood cells may also leak through the damaged filters, causing hematuria (blood in the urine). The abnormal red blood cells that appear in the urine are often distorted in shape, which helps doctors confirm that the bleeding is coming from the glomeruli rather than from somewhere else in the urinary system.[5]

Over time, if the inflammation and damage continue, the affected glomeruli become scarred and stop functioning entirely. This process, called glomerulosclerosis, is irreversible. As more and more glomeruli become scarred, the kidney’s overall filtering capacity declines. The kidney tries to compensate by making remaining glomeruli work harder, but this increased workload can cause them to fail more quickly. Eventually, if enough glomeruli are destroyed, the kidneys cannot adequately remove waste products from the blood, leading to chronic kidney failure.[1]

The rate at which this damage progresses varies considerably between individuals and depends on factors such as the specific type of MPGN, the severity of proteinuria, the presence of high blood pressure, and how well the underlying cause (if there is one) is treated. Some people progress slowly over many years, while others experience more rapid deterioration of kidney function.[6]

⚠️ Important
The disease can recur after kidney transplantation, especially in certain types of MPGN. This means that even after receiving a new kidney, some patients may develop the same disease in the transplanted kidney. This possibility is an important consideration when planning for kidney transplantation and emphasizes the need for ongoing medical monitoring even after successful transplant.

Ongoing Clinical Trials on Glomerulonephritis membranoproliferative

  • Study on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)

    Recruiting

    1 1
    Czechia Denmark France Germany Greece Italy +4
  • Study on the Safety and Effectiveness of Pegcetacoplan for Patients with Post-Transplant Recurrence of C3 Glomerulopathy or Immune Complex Membranoproliferative Nephritis

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Italy The Netherlands

References

https://medlineplus.gov/ency/article/000475.htm

https://emedicine.medscape.com/article/240056-overview

https://www.kidney.org/kidney-topics/immune-complex-membranoproliferative-glomerulonephritis-ic-mpgn

https://www.merckmanuals.com/professional/genitourinary-disorders/glomerular-disorders/membranoproliferative-glomerulonephritis

https://www.erknet.org/patients/lt/your-kidney-disease/mpgn/disease-information

https://pmc.ncbi.nlm.nih.gov/articles/PMC2887509/

https://emedicine.medscape.com/article/240056-treatment

https://www.kidney.org/kidney-topics/immune-complex-membranoproliferative-glomerulonephritis-ic-mpgn

https://pmc.ncbi.nlm.nih.gov/articles/PMC5440792/

https://pubmed.ncbi.nlm.nih.gov/8052369/

https://www.merckmanuals.com/professional/genitourinary-disorders/glomerular-disorders/membranoproliferative-glomerulonephritis

https://emedicine.medscape.com/article/240056-medication

https://www.kidney.org/kidney-topics/immune-complex-membranoproliferative-glomerulonephritis-ic-mpgn

https://emedicine.medscape.com/article/240056-treatment

https://sensus.org/news/navigating-life-kidney-disease

https://www.kidney.org.uk/membranoproliferative-glomerulonephritis-mpgn

https://www.mykidneydiseaseteam.com/resources/tips-for-reducing-stress-with-kidney-disease

https://ufhealth.org/conditions-and-treatments/membranoproliferative-glomerulonephritis

https://www.kidney.org/kidney-topics/glomerulonephritis

https://www.youtube.com/watch?v=gCQyiAIcNlk

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://pmc.ncbi.nlm.nih.gov/articles/PMC6558629/

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

How is membranoproliferative glomerulonephritis diagnosed?

Diagnosis is confirmed through a kidney biopsy, where a small sample of kidney tissue is examined under a microscope. Doctors look for specific patterns of damage and deposits. Additional tests include blood tests to check complement levels and kidney function, urine tests to measure protein and blood in the urine, and various tests to identify any underlying conditions that might be causing the disease.

What is the outlook for someone diagnosed with MPGN?

The outlook varies depending on the type of MPGN and individual factors. The disease often progresses slowly, and about half of people with this condition develop chronic kidney failure within 10 years. However, outcomes are generally better in children than adults, and treatment effectiveness depends on factors such as the severity of protein loss in the urine and whether an underlying cause can be identified and treated.

Can membranoproliferative glomerulonephritis be cured?

There is currently no definitive cure for primary MPGN, but the disease can sometimes go into remission. For secondary MPGN caused by infections or other conditions, treating the underlying cause can sometimes resolve or improve the kidney disease. The goal of treatment is typically to slow disease progression, manage symptoms, and prevent complications rather than achieve a complete cure.

Will I need dialysis or a kidney transplant?

Not everyone with MPGN will need dialysis or transplant, but these treatments may eventually become necessary if the disease progresses to kidney failure. The need depends on how rapidly the disease advances, how well treatment works, and individual factors. Regular monitoring helps doctors predict if and when kidney replacement therapy might be needed.

What dietary changes are recommended for MPGN?

Dietary recommendations typically include limiting sodium to help control blood pressure and reduce swelling, moderating protein intake to reduce kidney workload, and sometimes restricting fluids if swelling is significant. However, specific dietary needs vary greatly between individuals, so changes should be made under the guidance of healthcare providers or a renal dietitian who can tailor recommendations to your specific situation.

🎯 Key takeaways

  • MPGN primarily affects children and young adults between ages 8 and 30, though it can occur at any age, and it represents less than 10% of nephrotic syndrome cases in children.
  • Modern classification now focuses on what causes the disease rather than just appearance, dividing MPGN into immune complex-mediated, complement-mediated, and types without deposits.
  • Chronic infections, especially hepatitis C, are now recognized as major causes of what were once thought to be unexplained cases, changing treatment approaches dramatically.
  • The characteristic “tram-track” or “double-contour” appearance of the glomerular basement membrane under a microscope is a distinctive feature that helps doctors identify MPGN.
  • Low complement levels in the blood (hypocomplementemia) are frequently present and provide supportive evidence for diagnosis, though the specific complement changes vary by MPGN type.
  • About half of people with MPGN develop chronic kidney failure within 10 years, making early diagnosis and consistent monitoring crucial for managing the disease effectively.
  • Treatment approaches vary based on disease severity and type, ranging from supportive care and blood pressure control to immunosuppressive medications and, in some cases, newer complement-targeting therapies.
  • The disease can recur in transplanted kidneys, especially certain types, making ongoing medical supervision essential even after successful kidney transplantation.

Connected medications: